Articles

Poll

Podcasts

Slideshows

Videos

Gastroenterology

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.

Study findings highlight the prevalence of steroid use in IBD care and identify key subgroups at higher risk of exposure.

Young Women With Ulcerative Colitis Face Higher Corticosteroid Exposure Risk

Nedelkopoulou emphasizes the importance of structured and multidisciplinary transition programs for young patients with IBD and HPB disease.

Unraveling the Complexities of Concomitant IBD and Hepatobiliary Disease, With Natalia Nedelkopoulou, MD

Catch up on GI FDA news, new American Gastroenterological Association Crohn’s disease guidelines, and more gastroenterology updates from November.

5 Gastroenterology Headlines You Missed in November 2025

State- and local-level disparities in the availability of gastroenterologist care disproportionately affect patients with IBD and populations living in rural and high-poverty areas.

Geographic Disparities in GI Specialist Availability Suggest Limited Access to Care

The living guideline incorporates new medications and the latest data to make recommendations for moderate-to-severely active CD care.

AGA Releases Updated Clinical Crohn’s Disease Guideline Reflecting New Therapies

Sands explains the potential benefits of obefazimod and reviews findings from ABTECT 1 and ABTECT 2 presented at ACG 2025.

Obefazimod As An “Exciting” Potential Treatment for Ulcerative Colitis, With Bruce Sands, MD

Late-breaking ACG 2025 data link rimegepant to increased rectal compliance and reduced rectal sensation in IBS without constipation.


Rimegepant Linked to Increased Rectal Compliance, Reduced Rectal Sensation in IBS, With Ayah Matar, MD

Afzali details GALAXI post hoc findings on guselkumab in Crohn’s disease.


Guselkumab Shows Improved Outcomes in Crohn’s Disease: Insights From GALAXI, With Anita Afzali, MD

Check out the latest GI FDA news, new trial data in IBD, headlines from ACG 2025, and more.

6 Gastroenterology Headlines You Missed in October 2025

Keefer emphasizes the importance of treatment satisfaction and health-related quality of life in IBD and reviews findings from ASPIRE-CD.

HRQoL, Treatment Satisfaction With Risakizumab in ASPIRE-CD, With Laurie Keefer, PhD

On the HCPLive inflammatory bowel disease page, resources on the topics of medical news and expert insight into IBD can be found. Content includes articles, interviews, videos, podcasts, and breaking news on IBD and more.

Inflammatory Bowel Disease